Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 (HEMAJA)

Institut Paoli-Calmettes

Status: Completed

Conditions: Hodgkin Lymphoma; Acute Leukemia; Non-hodgkin Lymphoma; Malignant Haemopathies

Treatments: Drug: administered therapeutic regimens

Study type: Observational

Funder types: Other

Identifiers

NCT03469921

HEMAJA-IPC 2017-045

Details and patient eligibility

About

Unicentric retrospective analysis of a cohort of 602 young adult and adolescent patients, aged 15 to 30 years, with haematological malignancies, and managed between 2000 and 2016

Full description

The therapeutic results (response and survival) of young adult and adolescent patients with hematological malignancies are generally lower than those usually observed in adults over the age of 30, with equivalent treatment, particularly in lymphomatous pathology.The overall analysis of this large cohort of patients in its entirety, then by age groups (15-17 years, 18-25 years, 26-30 years) and pathology aims to describe the future of patients and patients. compare them to the results of the literature observed in this age group, and according to the therapeutic regimens administered (pediatric regimen or adult regimen).

Enrollment: 602 patients

Sex: All

Ages: 15 to 30 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Malignant hemopathies (acute leukemia, non-Hodgkin's lymphoma, Hodgkin's lymphoma) in primary care between 2000 and 2016.

Exclusion criteria

• Not applicable

Trial design

602 participants in 10 patient groups

15-17 years old

Description:

15-17 years old

Treatment:

Drug: administered therapeutic regimens

18-25 years old

Description:

18-25 years old

Treatment:

Drug: administered therapeutic regimens

26-30 years old

Description:

26-30 years old

Treatment:

Drug: administered therapeutic regimens

acute leukemia

Description:

acute leukemia

Treatment:

Drug: administered therapeutic regimens

non-Hodgkin's lymphoma

Description:

non-Hodgkin's lymphoma

Treatment:

Drug: administered therapeutic regimens

Hodgkin lymphoma

Description:

Hodgkin lymphoma

Treatment:

Drug: administered therapeutic regimens

pediatric therapeutic regimen administered

Description:

pediatric therapeutic regimen administered

Treatment:

Drug: administered therapeutic regimens

adult therapeutic regimen administered

Description:

adult therapeutic regimen administered

Treatment:

Drug: administered therapeutic regimens

patients included in clinical trials

Description:

patients included in clinical trials

Treatment:

Drug: administered therapeutic regimens

patients not included in clinical trials

Description:

patients not included in clinical trials

Treatment:

Drug: administered therapeutic regimens